Complexes [Pt(mu-N,S-8-TT)(PPh(3))(2)](2) (1), [Pt(mu-S,N-8-TT)(PTA)(2)](2) (2), [Pt(8-TTH)(terpy)]BF(4) (3), cis-[PtCl(8-MTT)(PPh(3))(2)] (4), cis-[Pt(8-MTT)(2)(PPh(3))(2)] (5), cis-[Pt(8-MTT)(8-TTH)(PPh(3))(2)] (6), cis-[PtCl(8-MTT)(PTA)(2)] (7), cis-[Pt(8-MTT)(2)(PTA)(2)] (8), and trans-[Pt(8-MTT)(2)(py)(2)] (9) (8-TTH(2) = 8-thiotheophylline; 8-MTTH = 8-(methylthio)theophylline; PTA = 1,3,5-triaza-7-phosphaadamantane) are presented and studied by IR and multinuclear ((1)H, (31)P[(1)H]) NMR spectroscopy. The solid-state structure of 4 and 9 has been authenticated by X-ray crystallography. Growth inhibition of the cancer cells T2 and SKOV3 induced by the above new thiopurine platinum complexes has been investigated. The activity shown by complexes 4 and 9 was comparable with cisplatin on T2. Remarkably, 4 and 9 displayed also a valuable activity on cisplatin-resistant SKOV3 cancer cells.
The interaction of the PTA (PTA = 1,3,5-triaza-7-phosphaadamantane) ruthenium complex trans-[RuCl(2)(PTA)(4)] (trans-1) with visible light in chloroform and in water has been studied at room temperature. The complex trans-1 isomerizes to the cis isomer in CHCl(3) with radiation of lambda > 416 nm (Phi(434 nm) (CHCl(3)) = 0.13 +/- 0.01). The isomerization reaction is reversible as cis-1 is transformed into trans-1 with lambda = 367 nm (Phi(367 nm) (CHCl(3)) = 0.25 +/- 0.02). Irradiation at lambda > 416 nm of a solution of trans-1 in water leads to the cis-isomer complex and to the aqua complex (OC-6-32)-[RuCl(H(2)O)(PTA)(4)]Cl (2Cl) by a photoisomerization and photoaquation reaction (Phi(434 nm) (D(2)O) = 0.27 +/- 0.02). The mole ratio of cis-1 to 2Cl is not dependent on the pH but on the concentration of the products in solution. Isomerization in water is not reversible even if only cis-1 is present in solution. Synthesis and characterization of (OC-6-32)-[RuCl(H(2)O)(PTA)(4)](CF(3)SO(3)) (2CF(3)SO(3)) are also presented.
The platinum mixed-phosphine complexes (SP-4,2)-[PtCl(8-MTT)(PPh3)(PTA)] (2) and cis-[Pt(8-MTT)2(PPh3)(PTA)] (3) (MTTH2 = 8-(methylthio)theophylline, PTA = 1,3,5-triaza-7-phosphaadamantane) have been prepared from the precursor cis-[PtCl2(PPh3)(PTA)] (1), which has been fully characterized by X-ray diffraction determination. Antiproliferative activity tests indicated that the presence of one lipophilic PPh3 and one hydrophilic PTA makes 1-3 more active than the analogues bearing two PPh3 or two PTA. The reactivity of cis-[PtCl2(PPh3)2], cis-[PtCl2(PTA)2], and cis-[PtCl2(PPh3)(PTA)] with the bis(thiopurines) bis(S-8-thiotheophylline)methane (MBTTH2), 1,2-bis(S-8-thiotheophylline)ethane (EBTTH2), and 1,3-bis(S-8-thiotheophylline)propane (PBTTH2) has also been investigated. New binuclear complexes have been prepared and identified by spectroscopic techniques and their antiproliferative activities on T2 and SKOV3 cell lines evaluated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.